GCDTR Mission

With its broad base of expertise, the mission of the Georgia Center for Diabetes Translation Research (GCDTR) is to facilitate and grow Type 2 translation research in diabetes within the state of Georgia. Type 2 translation is defined as research focused on translating approaches that have clearly demonstrated efficacy into real world health care settings, and communities, at risk with an emphasis on reach, sustainability, and widespread implementation.

Read More....

Awards

Micro Grant Rapid Funding Mechanism Announced

The Georgia Center for Diabetes Translation Research (GCDTR) is pleased to announce a Micro Grant Rapid Funding Mechanism (MGRFM). This is a unique competitive opportunity being offered by the GCDTR to provide timely and critical resources that can be leveraged by investigators for the submission of larger research funding requests. Award amounts will range from $500 to $2,000. The MGRFM grants will support diabetes translation research leading to the submission of an NIH (preferably) or other extramural research funding application that addresses themes encompassed in GCDTR’s research cores (www.gcdtr.org/core-programs/).

Funds are intended to be used to:

  • Enable a new NIH or other extramural application that is expected to be submitted within the next 6 to 12 months
  • Gather data needed for a scored NIH or other extramural application that is currently being revised for resubmission

Full instructions here and application here


Contact Us:

gcdtr@emory.edu


Publications

Preparedness cycle to address transitions in diabetes care during the COVID-19 pandemic and future outbreaks
Unjali P. Gujral, Leslie Johnson, Jannie Nielsen, Priyathama Vellanki, J. Sonya Haw, Georgia M. Davis, Mary Beth Weber, Francisco J. Pasquel
BMJ Open Diabetes Research & Care - 2020 Jul;8(1):e001520.
The authors describe how to respond to the public health crisis focused on diabetes care in the USA. They present strategies to address and evaluate transitions in diabetes care occurring in the immediate short-term (ie, response and mitigation), as well as phases to adapt and enhance diabetes care during the months and years to come while also preparing for future pandemics (ie, recovery, surveillance, and preparedness).

Implementation of Continuous Glucose Monitoring in the Hospital: Emergent Considerations for Remote Glucose Monitoring During the COVID-19 Pandemic
Rodolfo J. Galindo, Grazia Aleppo, David C. Klonoff, Elias K. Spanakis, Shivani Agarwal, Priya Vellanki, Darin E. Olson, Guillermo E. Umpierrez, Georgia M. Davis, Francisco J. Pasquel
Journal of Diabetes Science and Technology - 2020 Jul;14(4):822-832.
In this commentary, the authors analyze the answers to six questions about what is needed to bring CGM into the hospital as a reliable, safe, and effective tool, especially with regard to those patients with COVID-19.

Tailoring lifestyle programmes for diabetes prevention for US South Asians
Mary Beth Weber, Monique M. Hennink, K.M. Venkat Narayan
Family Medicine and Community Health - 2020 Apr 1;8(2):e000295.
The purpose of this study was to develop and test the feasibility of a culturally tailored Diabetes Prevention Program (DPP) for US South Asians, a large population with high diabetes risk.

 


More here

News

DIABETES PREVENTION WORKING GROUP

Are you interested in diabetes prevention research? Researchers at Emory are forming a working group to provide support and discussion around diabetes prevention and diabetes prevention research. This group will convene monthly to:

  • Provide a platform for members to present current ideas, on-going research, and research presentations for peer feedback
  • Discuss new findings in diabetes prevention research
  • Allow opportunities for networking and forming new collaborations 

If you are interested in joining us or for more information, please email Dr. Mary Beth Weber at mbweber@emory.edu.

 

COVID-19 HEALTH EQUITY DASHBOARD

To track and respond to this differential health impact, EGDRC, under the direction of Shivani Patel, has developed a COVID-19 Health Equity Dashboard (https://covid19.emory.edu). This is a dynamic and interactive web-based dashboard to visualize the interplay between social determinants and COVID-19 epidemiologic metrics at the county level. The dashboard was designed to be a public-facing tool that curates, disseminates and ultimately synthesizes actionable information to guide localized response to the epidemic over time. Current functionality allows users to quickly compare each county’s COVID-19 cases, deaths, and social characteristics to the state and national average; visualize the relationship between social determinants and COVID-19 outcomes; view a printer-friendly report of detailed county data; and create side-by-side maps comparing key metrics at the county level. View

COVID-19 AND DIABETES: CURRENT AND FUTURE IMPACTS (Webinar April 3, 2020)

Recording available here and below:

Synopsis of the Epidemiology

  • Coronavirus infection in people with diabetes
  • Outcomes in people with diabetes

Management of Diabetes in the Time of COVID-19

  • Switching to telemedicine
  • What can and can’t you do?

What is the path forward after the pandemic?

  • Will diabetes care/management ever be the same?

Panelists:

  • Carlos del Rio, MD
    Executive Associate Dean, Emory School of Medicine at Grady Health System
    Professor, Emory University School of Medicine, Division of Infectious Diseases
    Co-Director, Emory Center for AIDS Research
  • Guillermo Umpierrez, MD
    Chief of Diabetes and Endocrinology, Grady Health Systems
    Professor, Emory University School of Medicine, Division of Endocrinology
    Associate Director, Georgia Center for Diabetes Translation Research
  • Mohammed K. Ali, MD, MSc, MBA
    Associate Professor, Department of Family and Preventive Medicine, Emory School of Medicine
    and Department of Global Health, Rollins School of Public Health
    Associate Director, Georgia Center for Diabetes Translation Research
  • Shivani Agarwal, MD
    Assistant Professor, Department of Medicine (Endocrinology)
    Albert Einstein College of Medicine

Moderator:

  • K.M. Venkat Narayan, MD, MSc, MBA
    Director, Georgia Center for Diabetes Translation Research
    Director, Emory Global Diabetes Research Center
    Ruth and O.C. Hubert Professor, Department of Global Health, Rollins School of Public Health